Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 58 P075 | DOI: 10.1530/endoabs.58.P075

BSPED2018 Poster Presentations Diabetes (40 abstracts)

Case series of monogenic diabetes due to HNF1B mutation

Ayman Elhomoudi , V Tziaferi , James Greening & Prem Sundaram


University Hospitals of Leicester, Leicester, UK.


Introduction: A case series of three children diagnosed with MODY at a university hospital between November 2015 and May 2018. All of them was found to have HNF1B mutation.

Background: HNF1β-MODY (MODY5) is a rare form of monogenic diabetes that is often associated with a wide range of urinary tract anomalies including renal cysts. It’s a dominantly inherited disease including maturity-onset diabetes of the young (MODY), pancreatic insufficiency and some psychological disorders. Clinical presentation of renal cyst and diabetes syndrome (RCAD) includes renal involvement, deranged liver function, hyperuricemia and early-onset gout and reproductive tract abnormalities. In this case series report, we describe 3 cases of atypical non-autoimmune diabetes associated with a confirmed HNF1β mutation.

Management: Two children needed insulin for their diabetes management. Emphasis should be on lifestyle modifications such as weight loss and diet control. All three cases and their families had extensive genetic counseling and advise.

Conclusion: In our case series, we have shown that early diagnosis of HNF1B disease in childhood can help in early detection and management of diabetes and other co-morbidities. Co-morbidities include electrolytes imbalance, liver enzymes derangement, exocrine pancreas insufficiency and Psychological disorders were detected in case one and three. Molecular diagnosis has huge implications for the counselling and treatment of the patients and their family members.

Clinical presentations: See Table 1.

Table 1
Case 1Case 2Case 3
Age at diagnosis (years)/sex15/Male13/Male12/Male
BMI at diagnosis kg/m2 (SDS)33 (2.96)18.4 (0.06)34 (3.35)
HbA1c at diagnosis (mmol/mol)117 (12.8%)55 (7.1%)52 (6.9%)
Initial treatmentMDI regimeGliclazideMetformin
Renal scan findingsNormalEchogenic kidneys and single cystSingle renal cyst
MODY geneticsHNF1B whole gene deletionChromosome 17q12 micro-deletion including HNF1B gene deletionHNF1B c.884G>A
Other morbiditiesDepression, ASD, ADHDExocrine pancreas insufficiencyDepression
Present treatmentMDI insulin+ MetforminInsulin BD regimeMetformin
Family historyType 2 diabetesMother and half-sister have same mutationMother type1, grandmother type2
Recent HbA1c (mmol/mol)42 (6%)51 (6.8%)42 (6%)
Diabetes antibodiesNegativeAnti-GAD antibody 28Negative

Volume 58

46th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Birmingham, UK
07 Nov 2018 - 09 Nov 2018

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts